Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163
PLOS Biology · 11.07.2025 · 23 (7) · e3003264
DOI: 10.1371/journal.pbio.3003264 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 11.07.2025. Verfasst von Ching-Shin Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: BioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Haptoglobins, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Antigens, CD. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Inc., Cambridge, MA, USA, Pfizer, Inc.
Abstract (Originalsprache)
Intravascular hemolysis releases hemoglobin into the bloodstream, which can damage vascular and renal tissues due to its oxidative nature. Circulating haptoglobin acts as a primary defense by binding to free hemoglobin, forming a haptoglobin–hemoglobin (HpHb) complex that is then recognized and cleared by the CD163 scavenger receptor on macrophages. While the function and structure of HpHb complex are mostly well-defined, the molecular mechanism underlying its interaction with CD163 remains unclear. Here we report the cryo-electron microscopy structures of human CD163 in its unliganded state and in its complex with HpHb. These structures reveal that CD163 functions as a trimer, forming a composite binding site at its center for one protomer of the dimeric HpHb, resulting in a 3:1 binding stoichiometry. In the unliganded state, CD163 can also form a trimer, but in an autoinhibitory configuration that occludes the ligand binding site. Widespread electrostatic interactions mediated by calcium ions are pivotal in both pre-ligand and ligand-bound receptor assemblies. This calcium-dependent mechanism enables CD163/HpHb complexes to assemble and, once internalized, disassemble into individual components upon reaching the endosome, where low calcium and lower pH conditions prevail. Collectively, this study elucidates the molecular mechanism by which CD163-mediated endocytosis efficiently clears different isoforms of HpHb.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- BioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.
- BioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
- School of Molecular and Cellular Biology, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
- School of Biomedical Sciences, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
ORCID-Profile: Ching-Shin Huang
Förderung
- Pfizer, Inc., Cambridge, MA, USA
- Pfizer, Inc
Zitieren
APA
Huang, C. S., Wang, H., White, J. B. R., Degtjarik, O., Huynh, C., Brannstrom, K., Horn, M. T., Muench, S. P., Somers, W. S., Chaparro-Riggers, J., Lin, L., & Mosyak, L. (2025). Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163. PLOS Biology, 23(7), e3003264. https://doi.org/10.1371/journal.pbio.3003264
Vancouver
Huang CS, Wang H, White JBR, Degtjarik O, Huynh C, Brannstrom K, et al. Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163. PLOS Biology. 2025;23(7):e3003264. doi:10.1371/journal.pbio.3003264
BibTeX
@article{Huang2025,
author = {Huang, Ching-Shin and Wang, Hui and White, Joshua B R and Degtjarik, Oksana and Huynh, Cindy and Brannstrom, Kristoffer and Horn, Mark T and Muench, Stephen P and Somers, William S and Chaparro-Riggers, Javier and Lin, Laura and Mosyak, Lidia},
title = {Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {7},
pages = {e3003264},
doi = {10.1371/journal.pbio.3003264}
}
EUVIMED